Document Detail

Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis.
MedLine Citation:
PMID:  18773999     Owner:  NLM     Status:  MEDLINE    
It has been suggested that statins could slow the progression of aortic stenosis (AS), but this hypothesis is still debated and has not been validated in large series of patients by long-term follow-up studies. Moreover, information about the role of statins in patients with different degrees of severity of AS is scarce. From our 1988 to 2007 echocardiographic database, we retrospectively identified all asymptomatic patients with aortic valve sclerosis (abnormal irregular thickening of the aortic valve with a peak aortic velocity [Vmax] > or =1.5 and <2 m/s), mild AS (Vmax > or =2 and <3 m/s), and moderate AS (Vmax > or =3 and <4 m/s), age > or =50 years, and with > or =2 echocardiographic studies > or =2 years apart. Exclusion criteria were moderate/severe aortic regurgitation, bicuspid aortic valve, rheumatic valve disease, and ejection fraction <40%. The final study population consisted of 1,046 patients (mean age 70 +/- 8 years, 587 men); 309 were treated with statins. Mean follow-up duration was 5.6 +/- 3.2 years (range 2 to 19). Progression of AS was slower in patients receiving statins compared with untreated patients in aortic sclerosis (0.04 +/- 0.09 vs 0.07 +/- 0.10 m/s/year, p = 0.01) and mild AS (0.09 +/- 0.15 vs 0.15 +/- 0.15 m/s/year, p = 0.001), but not in moderate AS (0.21 +/- 0.18 vs 0.22 +/- 0.15 m/s/year, p = 0.70). In multivariate analysis only statin therapy, initial Vmax, and dialysis were independently related to progression of aortic valve disease. In conclusion, in a large series of patients with long-term follow-up, statins were effective in slowing the progression of aortic valve disease in aortic sclerosis and mild AS, but not in moderate AS. These results suggest that statin therapy should be taken into consideration in the early stages of this common disease.
Francesco Antonini-Canterin; Monica Hîrşu; Bogdan Alexandru Popescu; Elisa Leiballi; Rita Piazza; Daniela Pavan; Carmen Ginghină; Gian Luigi Nicolosi
Related Documents :
7881659 - Transient increase in interleukin-8 and pulmonary microvascular permeability following ...
16607909 - Fate of the autograft and homograft following ross aortic valve replacement: reoperativ...
12022529 - Isolated myocardial revascularization with intermittent aortic cross-clamping: experien...
10391359 - Surgery for acute type a aortic dissection: the hopital foch experience (1977-1998).
2522289 - Pharmacokinetics of sufentanil in patients undergoing abdominal aortic surgery.
18154789 - Enlargement of the small aortic root during aortic valve replacement: is there a benefit?
6279229 - Burst abdomen and incisional hernia: a prospective study of 1129 major laparotomies.
24045349 - Are there differences between maori and non-maori patients undergoing primary total hip...
19572209 - Ten years single surgeon experience with botulinum toxin in the urinary tract; clinical...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-06-26
Journal Detail:
Title:  The American journal of cardiology     Volume:  102     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2008 Sep 
Date Detail:
Created Date:  2008-09-08     Completed Date:  2008-10-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  738-42     Citation Subset:  AIM; IM    
Cardiologia Association for Research in Cardiology, Azienda Ospedaliera S. Maria degli Angeli, Pordenone, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aortic Valve / pathology*
Aortic Valve Stenosis / drug therapy*
Blood Flow Velocity
Disease Progression
Follow-Up Studies
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Kidney Failure, Chronic / therapy
Multivariate Analysis
Renal Dialysis
Retrospective Studies
Severity of Illness Index*
Reg. No./Substance:
0/Hydroxymethylglutaryl-CoA Reductase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict card...
Next Document:  Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by ato...